AXL-IN-13
AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM. It exhibits anticancer activity, reverses TGF-β1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion.
Product Specifications
CAS Number
2376928-82-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
632.72
Molecular Formula
C34H41FN6O5
Notes
Research use only, not for human use.
Receptor
FLT | PDGFR | TGF-beta/Smad | TAM Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15160037 1 Vial
Lentiviral mouse Slamf8 shRNA (UAS) - Lentiviral mouse Slamf8 shRNA (UAS) (25)
Ask
View Details 
7184-RTM2-P1 100ug
Anti-GRP94/ HSP90B1 Antibody Clone HSP90B1/1192, Unconjugated-100ug
Ask
View Details 032048-FITC 200 µL
ARHGEF16, NT (ARHGEF16, EPHEXIN4, NBR, Rho guanine nucleotide exchange factor 16, Ephexin-4) (FITC) discontinued
Ask
View Details 
